The Influence of simvastatin on NGAL, matrix metalloproteinases and their tissue inhibitors in human intraluminal thrombus and abdominal aortic aneurysm tissue

European Journal of Vascular and Endovascular Surgery

Volumn 49, Issue 5, 2015, Pages 549-555

  Piechota Polanczyk, A ^a   Demyanets, S ^a   Mittlboeck, M ^a   Hofmann, M ^a   Domenig, C M ^a   Neumayer, C ^a   Wojta, J ^a   Klinger, M ^a   Nanobachvili, J ^a   Huk, I ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abdominal aortic aneurysm; NGAL; Simvastatin; Thrombus; TIMP

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIMVASTATIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; ACUTE PHASE PROTEIN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; ONCOPROTEIN; TIMP1 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; INTRALUMINAL THROMBUS; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; THROMBUS; AORTIC ANEURYSM, ABDOMINAL; METABOLISM; MIDDLE AGED; THROMBOSIS;

ACUTE-PHASE PROTEINS; AGED; AORTIC ANEURYSM, ABDOMINAL; FEMALE; HUMANS; LIPOCALINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SIMVASTATIN; THROMBOSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84933177516     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2015.02.011     Document Type: Article

References (31)

1. Hannawa KK, Eliason JL, Woodrum DT, Pearce CG, Roelofs KJ, Grigoryants V, et al. L-selectin-mediated neutrophil recruitment in experimental rodent aneurysm formation. Circulation 2005;112:241-7.
2. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005;365:1577-89.
3. Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan Jr WD, Blebea J, et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002;287:2968-72.
4. Piechota-Polanczyk A, Goraca A, Demyanets S, Mittlboeck M, Domenig C, Neumayer C, et al. Simvastatin decreases free radicals formation in the human abdominal aortic aneurysm wall via NF-kappaB. Eur J Vasc Endovasc Surg 2012;44:133-7.
5. Piechota-Polanczyk A, Demyanets S, Nykonenko O, Huk I, Mittlboeck M, Domenig CM, et al. Decreased tissue levels of cyclophilin A, a cyclosporine a target and phospho-ERK1/2 in simvastatin patients with abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2013;45:682-8.
6. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998;102:1900-10.
7. Liao JK. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 2005;96:24F-33F.
8. Folkesson M, Kazi M, Zhu C, Silveira A, Hemdahl AL, Hamsten A, et al. Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb Haemost 2007;98:427-33.
9. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 2000;105:1641-9.
10. Swedenborg J, Eriksson P. The intraluminal thrombus as a source of proteolytic activity. Ann N Y Acad Sci 2006;1085:133-8.
11. Koole D, Zandvoort HJ, Schoneveld A, Vink A, Vos JA, van den Hoogen LL, et al. Intraluminal abdominal aortic aneurysm thrombus is associated with disruption of wall integrity. J Vasc Surg 2013;57:77-83.
12. de Franciscis S, Mastroroberto P, Gallelli L, Buffone G, Montemurro R, Serra R. Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm. Ann Vasc Surg 2013;27:1185.e5-7.
13. Serra R, Volpentesta G, Gallelli L, Grande R, Buffone G, Lavano A, et al. Metalloproteinase-9 and neutrophil gelatinaseassociated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms. Br J Neurosurg 2014. http://dx.doi.org/10.3109/02688697.2014.913777.
14. Zografos T, Haliassos A, Korovesis S, Giazitzoglou E, Voridis E, Katritsis D. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease. Am J Cardiol 2009;104:917-20.
15. Khan JA, Abdul Rahman MN, Mazari FA, Shahin Y, Smith G, Madden L, et al. Intraluminal thrombus has a selective influence on matrix metalloproteinases and their inhibitors (tissue inhibitors of matrix metalloproteinases) in the wall of abdominal aortic aneurysms. Ann Vasc Surg 2012;26:322-9.
16. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 1996;800:157-74.
17. Evans J, Powell JT, Schwalbe E, Loftus IM, Thompson MM. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg 2007;34:302-3.
18. Karlsson L, Bergqvist D, Lindback J, Parsson H. Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma. Eur J Vasc Endovasc Surg 2009;37:420-4.
19. Mastoraki ST, Toumpoulis IK, Anagnostopoulos CE, Tiniakos D, Papalois A, Chamogeorgakis TP, et al. Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits. Ann Vasc Surg 2012;26:250-8.
20. Hurks R, Hoefer IE, Vink A, Pasterkamp G, Schoneveld A, Kerver M, et al. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. Eur J Vasc Endovasc Surg 2010;39:569-76.
21. Muehling B, Oberhuber A, Schelzig H, Bischoff G, Marx N, Sunder-Plassmann L, et al. Effect of statin therapy on serum activity of proteinases and cytokines in patients with abdominal aortic aneurysm. Vasc Health Risk Manag 2008;4:1433-7.
22. Weintraub NL. Understanding abdominal aortic aneurysm. N Engl J Med 2009;361:1114-6.
23. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110:625-32.
24. Wiernicki I, Stachowska E, Safranow K, Cnotliwy M, Rybicka M, Kaczmarczyk M, et al. Enhanced matrix-degrading proteolytic activity within the thin thrombus-covered wall of human abdominal aortic aneurysms. Atherosclerosis 2010;212:161-5.
25. Kajimoto K, Miyauchi K, Kasai T, Shimada K, Kojima Y, Shimada A, et al. Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. Atherosclerosis 2009;206:505-11.
26. Watanabe A, Ichiki T, Sankoda C, Takahara Y, Ikeda J, Inoue E, et al. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption. Clin Sci (Lond) 2014;126:671-8.
27. Zhang H, Wang ZW, Wu HB, Li Z, Li LC, Hu XP, et al. Transforming growth factor-beta1 induces matrix metalloproteinase-9 expression in rat vascular smooth muscle cells via ROS-dependent ERK-NF-kappaB pathways. Mol Cell Biochem 2013;375:11-21.
28. Kjeldsen L, Cowland JB, Borregaard N. Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse. Biochim Biophys Acta 2000;1482:272-83.
29. Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol Chem 1997;378:71-6.
30. Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M, Blanco-Colio LM, Meilhac O, Feldman L, et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 2012;220:552-6.
31. Te Boekhorst BC, van Tilborg GA, Strijkers GJ, Nicolay K. Molecular MRI of inflammation in atherosclerosis. Curr Cardiovasc Imaging Rep 2012;5:60-8.